B
Bladder cancer: (2005) Adjuvant chemotherapy, systematic review and IPD meta-analysis
Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data
Bladder cancer: (2022) Adjuvant chemotherapy, systematic review and IPD meta-analysis
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials
Bladder cancer: Neoadjuvant chemotherapy, systematic review and IPD meta-analysis
Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data
BLISTER
The bullous pemphigoid steroids and tetracyclines study
BLT
Big Lung Trial: A randomised trial to determine the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer
BO01
Two adjuvant chemotherapy regimens in the treatment of osteosarcoma
BO02
A randomised pilot study of two drug combinations in patients with osteosarcoma
BO03
A randomised trial of two-drug versus multi-drug chemotherapy in the treatment of operable osteosarcoma
BO04
A phase II study of cisplatin, ifosfamide and doxorubicin (PIA) chemotherapy in operable primary, axial skeletal and metastatic osteosarcoma
BO05
A phase II study of Adriamycin and cisplatin in spindle cell sarcoma of bone other than osteosarcoma
BO06
A randomised trial of chemotherapy with or without granulocyte colony stimulating factor (G-CSF) in operable osteosarcoma
BR01
Medical Research Council Study of Misonidazole in Conjunction with Radiotherapy for the Treatment of Malignant Gliomas (Astrocytomas) Grades III and IV
BR02
A Medical Research Council Study of Two Radiotherapy Dose Regimens for the Treatment of Adult Patients with Malignant Gliomas Grades III and IV
BR03
A study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytomas
BR04
Randomised trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: EORTC 22845 randomised trial
BR05
A randomised trial of adjuvant chemotherapy in high grade malignant glioma
BR12
Temozolomide versus PCV chemotherapy in the treatment of recurrent malignant glioma
BR13
Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade glioma after stratification for genetic 1p loss: a phase III study. Intergroup Study (EORTC 22033-26033)
BR14
Phase III trial on concurrent and adjuvant temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial
BREATHER
Short-Cycle Therapy (SCT) (5 days on/2 days off) in young people with chronic HIV infection
BREATHER Plus
A randomised open label two-arm, 96 week trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir based triple antiretroviral therapy (ART) compared to daily dolutegravir/tenofovir based triple ART in virologically suppressed HIV infected adolescents aged 12 to 19 years of age in sub Saharan Africa